Cart
sales@molnova.com
Pectolinarigenin
CAS No. 520-12-7
Pectolinarigenin( Pectolinarigenin )
Catalog No. M18710 CAS No. 520-12-7
Pectolinarigenin possesses anti-inflammatory activity and that they may inhibit eicosanoid formation in inflammatory lesions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 86 | In Stock |
|
| 10MG | 149 | In Stock |
|
| 25MG | 266 | In Stock |
|
| 50MG | 410 | In Stock |
|
| 100MG | 619 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePectolinarigenin
-
NoteResearch use only, not for human use.
-
Brief DescriptionPectolinarigenin possesses anti-inflammatory activity and that they may inhibit eicosanoid formation in inflammatory lesions.
-
DescriptionPectolinarigenin possesses anti-inflammatory activity and may inhibit eicosanoid formation in inflammatory lesions.
-
In Vitro——
-
In Vivo——
-
SynonymsPectolinarigenin
-
PathwayMetabolic Enzyme/Protease
-
TargetMMP
-
RecptorOthers
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number520-12-7
-
Formula Weight314.29
-
Molecular FormulaC17H14O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 33.33 mg/mL (106.05 mM)
-
SMILESCOC1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)O)OC)O
-
Chemical Name5,7-Dihydroxy-6-methoxy-2-(4-methoxyphenyl)-4-benzopyrone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MMP2-IN-2
MMP2-IN-2 (compound 42) is a potent and selective inhibitor of MMP-2 (matrix metalloproteinases) with an IC50 of 4.2 μM, and it also shows inhibitory activity against MMP-13, MMP-9, and MMP-8 with IC50 values of 12, 23.3, and 25 μM, respectively .
-
Schaftoside
Schaftoside has antioxidant and anticancer activity.
-
PF 00356231
PF 00356231 is a selectivity inhibitor MMP-12 and can be used in studies about the treatment of emphysema and chronic obstructive pulmonary disease (COPD).
